SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 15th, 2024 • Annovis Bio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 15th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 15, 2024, is by and among Annovis Bio, Inc., a Delaware corporation with headquarters located at 101 Lindenwood Drive, Suite 225 Malvern, PA 19355 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).